The earnings transcript for UnitedHealth Group's third quarter of 2014 presents a mixed but generally positive outlook. Here are the key points that influence the short-term impact on the stock:

1. **Strong Financial Performance**: UnitedHealth Group reported revenue growth of 7% year-over-year, with earnings per share increasing by 7% to $1.63. Optum's revenues and earnings from operations also showed significant growth, contributing substantially to the company's overall performance.

2. **Guidance and Outlook**: The company affirmed its 2014 revenue outlook and raised its net earnings projection to a range of $5.60 to $5.65 per share. This indicates confidence in their ability to meet or exceed expectations for the year.

3. **Cost Management and Utilization**: UnitedHealth Group highlighted stable utilization trends and effective medical cost management, which are crucial for maintaining profitability. However, there are mentions of higher medical cost trends due to reform-related changes, which could be a slight concern but are managed through pricing discipline.

4. **Optum's Growth**: Optum's performance was particularly strong, with significant growth in OptumRx and OptumInsight. This segment is expected to continue contributing to the company's growth and is a positive indicator for future performance.

5. **Market Positioning**: The company is well-positioned in various markets, including Medicaid, Medicare Advantage, and commercial segments. Their strategy of transitioning more members to value-based care and improving clinical outcomes is seen as a long-term strength.

Given these points, the overall tone of the earnings call is positive, with strong financial performance, confident guidance, and a robust outlook for future growth. However, the short-term impact might be slightly tempered by the ongoing challenges in medical cost trends and the evolving healthcare landscape.

### Conclusion
The stock is likely to experience a positive impact in the short term due to the strong financial results, solid guidance, and optimistic outlook for future growth.

### Rating
[1]